List view / Grid view

Food and Drug Administration (FDA)

 

news

FDA approves schizophrenia treatment Aristada

7 October 2015 | By Victoria White

Aristada is the first atypical antipsychotic with once-monthly and six-week dosing options for delivering and maintaining therapeutic levels of medication in the body through an injection...